Cargando…

Sleeping Beauty transposon system for GDNF overexpression of entrapped stem cells in fibrin hydrogel in a rat model of Parkinson’s disease

There is currently no causal treatment available for Parkinson’s disease (PD). However, the use of glial cell line–derived neurotrophic factor (GDNF) to provide regenerative effects for neurons is promising. Such approaches require translational delivery systems that are functional in diseased tissu...

Descripción completa

Detalles Bibliográficos
Autores principales: Stahn, Laura, Rasińska, Justyna, Dehne, Tilo, Schreyer, Stefanie, Hakus, Aileen, Gossen, Manfred, Steiner, Barbara, Hemmati-Sadeghi, Shabnam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125957/
https://www.ncbi.nlm.nih.gov/pubmed/36853436
http://dx.doi.org/10.1007/s13346-023-01289-9
_version_ 1785030133167423488
author Stahn, Laura
Rasińska, Justyna
Dehne, Tilo
Schreyer, Stefanie
Hakus, Aileen
Gossen, Manfred
Steiner, Barbara
Hemmati-Sadeghi, Shabnam
author_facet Stahn, Laura
Rasińska, Justyna
Dehne, Tilo
Schreyer, Stefanie
Hakus, Aileen
Gossen, Manfred
Steiner, Barbara
Hemmati-Sadeghi, Shabnam
author_sort Stahn, Laura
collection PubMed
description There is currently no causal treatment available for Parkinson’s disease (PD). However, the use of glial cell line–derived neurotrophic factor (GDNF) to provide regenerative effects for neurons is promising. Such approaches require translational delivery systems that are functional in diseased tissue. To do so, we used a non-viral Sleeping Beauty (SB) transposon system to overexpress GDNF in adipose tissue–derived mesenchymal stromal cells (adMSCs). Entrapment of cells in fibrin hydrogel was used to boost potential neurorestorative effects. Functional GDNF-adMSCs were able to secrete 1066.8 ± 169.4 ng GDNF/120,000 cells in vitro. The GDNF-adMSCs were detectable for up to 1 month after transplantation in a mild 6-hydroxydopamine (6-OHDA) hemiparkinson male rat model. Entrapment of GDNF-adMSCs enabled GDNF secretion in surrounding tissue in a more concentrated manner, also tending to prolong GDNF secretion relatively. GDNF-adMSCs entrapped in hydrogel also led to positive immunomodulatory effects via an 83% reduction of regional IL-1β levels compared to the non-entrapped GDNF-adMSC group after 1 month. Furthermore, GDNF-adMSC-treated groups showed higher recovery of tyrosine hydroxylase (TH)-expressing cells, indicating a neuroprotective function, although this was not strong enough to show significant improvement in motor performance. Our findings establish a promising GDNF treatment system in a PD model. Entrapment of GDNF-adMSCs mediated positive immunomodulatory effects. Although the durability of the hydrogel needs to be extended to unlock its full potential for motor improvements, the neuroprotective effects of GDNF were evident and safe. Further motor behavioral tests and other disease models are necessary to evaluate this treatment option adequately. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13346-023-01289-9.
format Online
Article
Text
id pubmed-10125957
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-101259572023-04-26 Sleeping Beauty transposon system for GDNF overexpression of entrapped stem cells in fibrin hydrogel in a rat model of Parkinson’s disease Stahn, Laura Rasińska, Justyna Dehne, Tilo Schreyer, Stefanie Hakus, Aileen Gossen, Manfred Steiner, Barbara Hemmati-Sadeghi, Shabnam Drug Deliv Transl Res Article There is currently no causal treatment available for Parkinson’s disease (PD). However, the use of glial cell line–derived neurotrophic factor (GDNF) to provide regenerative effects for neurons is promising. Such approaches require translational delivery systems that are functional in diseased tissue. To do so, we used a non-viral Sleeping Beauty (SB) transposon system to overexpress GDNF in adipose tissue–derived mesenchymal stromal cells (adMSCs). Entrapment of cells in fibrin hydrogel was used to boost potential neurorestorative effects. Functional GDNF-adMSCs were able to secrete 1066.8 ± 169.4 ng GDNF/120,000 cells in vitro. The GDNF-adMSCs were detectable for up to 1 month after transplantation in a mild 6-hydroxydopamine (6-OHDA) hemiparkinson male rat model. Entrapment of GDNF-adMSCs enabled GDNF secretion in surrounding tissue in a more concentrated manner, also tending to prolong GDNF secretion relatively. GDNF-adMSCs entrapped in hydrogel also led to positive immunomodulatory effects via an 83% reduction of regional IL-1β levels compared to the non-entrapped GDNF-adMSC group after 1 month. Furthermore, GDNF-adMSC-treated groups showed higher recovery of tyrosine hydroxylase (TH)-expressing cells, indicating a neuroprotective function, although this was not strong enough to show significant improvement in motor performance. Our findings establish a promising GDNF treatment system in a PD model. Entrapment of GDNF-adMSCs mediated positive immunomodulatory effects. Although the durability of the hydrogel needs to be extended to unlock its full potential for motor improvements, the neuroprotective effects of GDNF were evident and safe. Further motor behavioral tests and other disease models are necessary to evaluate this treatment option adequately. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13346-023-01289-9. Springer US 2023-02-28 2023 /pmc/articles/PMC10125957/ /pubmed/36853436 http://dx.doi.org/10.1007/s13346-023-01289-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Stahn, Laura
Rasińska, Justyna
Dehne, Tilo
Schreyer, Stefanie
Hakus, Aileen
Gossen, Manfred
Steiner, Barbara
Hemmati-Sadeghi, Shabnam
Sleeping Beauty transposon system for GDNF overexpression of entrapped stem cells in fibrin hydrogel in a rat model of Parkinson’s disease
title Sleeping Beauty transposon system for GDNF overexpression of entrapped stem cells in fibrin hydrogel in a rat model of Parkinson’s disease
title_full Sleeping Beauty transposon system for GDNF overexpression of entrapped stem cells in fibrin hydrogel in a rat model of Parkinson’s disease
title_fullStr Sleeping Beauty transposon system for GDNF overexpression of entrapped stem cells in fibrin hydrogel in a rat model of Parkinson’s disease
title_full_unstemmed Sleeping Beauty transposon system for GDNF overexpression of entrapped stem cells in fibrin hydrogel in a rat model of Parkinson’s disease
title_short Sleeping Beauty transposon system for GDNF overexpression of entrapped stem cells in fibrin hydrogel in a rat model of Parkinson’s disease
title_sort sleeping beauty transposon system for gdnf overexpression of entrapped stem cells in fibrin hydrogel in a rat model of parkinson’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125957/
https://www.ncbi.nlm.nih.gov/pubmed/36853436
http://dx.doi.org/10.1007/s13346-023-01289-9
work_keys_str_mv AT stahnlaura sleepingbeautytransposonsystemforgdnfoverexpressionofentrappedstemcellsinfibrinhydrogelinaratmodelofparkinsonsdisease
AT rasinskajustyna sleepingbeautytransposonsystemforgdnfoverexpressionofentrappedstemcellsinfibrinhydrogelinaratmodelofparkinsonsdisease
AT dehnetilo sleepingbeautytransposonsystemforgdnfoverexpressionofentrappedstemcellsinfibrinhydrogelinaratmodelofparkinsonsdisease
AT schreyerstefanie sleepingbeautytransposonsystemforgdnfoverexpressionofentrappedstemcellsinfibrinhydrogelinaratmodelofparkinsonsdisease
AT hakusaileen sleepingbeautytransposonsystemforgdnfoverexpressionofentrappedstemcellsinfibrinhydrogelinaratmodelofparkinsonsdisease
AT gossenmanfred sleepingbeautytransposonsystemforgdnfoverexpressionofentrappedstemcellsinfibrinhydrogelinaratmodelofparkinsonsdisease
AT steinerbarbara sleepingbeautytransposonsystemforgdnfoverexpressionofentrappedstemcellsinfibrinhydrogelinaratmodelofparkinsonsdisease
AT hemmatisadeghishabnam sleepingbeautytransposonsystemforgdnfoverexpressionofentrappedstemcellsinfibrinhydrogelinaratmodelofparkinsonsdisease